about
Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritisImmunologists getting nervous: neuropeptides, dendritic cells and T cell activationAnti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor.Intestinal dendritic cells in the pathogenesis of inflammatory bowel disease.Health risks associated with inhaled nasal toxicants.Regulation of apoptosis by vasoactive peptides.Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV.Radical reversal of vasoactive intestinal peptide (VIP) receptors during early lymphopoiesisHorizons in Sjögren's syndrome genetics.Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome.NEUROPEPTIDES AND NEUROGENIC MECHANISMS IN ORAL AND PERIODONTAL INFLAMMATION.Molecular makeup of HIV-1 envelope protein.Ocular and systemic bio-distribution of rhodamine-conjugated liposomes loaded with VIP injected into the vitreous of Lewis rats.Experimental study on vasoactive intestinal peptide (VIP) and its diaminopropane bound (VIP-DAP) analog in solution.Inflammatory and immune pathways in the pathogenesis of periodontal disease.Inhibition of interferon (IFN) gamma-induced Jak-STAT1 activation in microglia by vasoactive intestinal peptide: inhibitory effect on CD40, IFN-induced protein-10, and inducible nitric-oxide synthase expression.Sensory neuron regulation of gastrointestinal inflammation and bacterial host defence.The ceramide-1-phosphate analogue PCERA-1 modulates tumour necrosis factor-alpha and interleukin-10 production in macrophages via the cAMP-PKA-CREB pathway in a GTP-dependent manner.The absence of the VPAC(2) receptor does not protect mice from Aspergillus induced allergic asthmaInhibition of endotoxin-induced macrophage chemokine production by VIP and PACAP in vitro and in vivo.Transglutaminase-mediated polyamination of vasoactive intestinal peptide (VIP) Gln16 residue modulates VIP/PACAP receptor activity.Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia.Vasoactive intestinal peptide impairs leucocyte migration but fails to modify experimental murine colitis.The effect of binge fetal alcohol exposure on the number of vasoactive intestinal peptide-producing neurons in fetal sheep brain.Preferential expression of the vasoactive intestinal peptide (VIP) receptor VPAC1 in human cord blood-derived CD34+CD38- cells: possible role of VIP as a growth-promoting factor for hematopoietic stem/progenitor cells.Therapeutic efficacy of vasoactive intestinal peptide in escherichia coli lipopolysaccharide-induced experimental periodontitis in rats.Association of neuropeptides with Th1/Th2 balance and allergic sensitization in children.
P2860
Q24795258-B3A11026-0B4C-4737-8EB3-E453AD8D4470Q28362884-89EBC193-3C1A-45E3-BCE0-C3F6688634C0Q33894893-4C0E1591-2309-4B9B-8E11-20AF2F0FC605Q34222959-B073FC93-C091-49C6-A8F1-134FAF0D5D7CQ34281120-4BF67B5B-6854-450A-8645-39F216FB0AD8Q34369962-2EBE42EF-DB87-45C7-89D8-23032951564AQ35061216-D6E71CE2-CE83-475B-B08D-B113415C6D8FQ35189265-122D0963-A988-4912-9061-C5B9C9DA9D7CQ35381048-0997A5AF-B785-4444-9909-9E132CCB8942Q35570872-3DB85EDB-83A7-47D1-A176-04F3C816BFAFQ35636782-7224FC52-9BD3-4F7B-87F3-6F5FA3786783Q35732409-57961D4B-637E-4909-B9EF-F0B24AFD01A7Q35888723-8C30D0E1-CE67-40BA-BE6A-3C2286E4BA21Q36498879-C43DD2A8-49B8-4CB5-A5D2-40BCA4BEB044Q36873919-5F08397A-5A50-46F5-B02F-10DD43C2586AQ38169798-002CD412-FBA7-4C71-8A39-539A391EBEF1Q38354522-F5F3ACF7-BE7C-4AA9-9DC7-E4197D6D91EBQ39117205-1D2746B0-F939-429E-9966-74B1D7780859Q39773317-FF05FFFF-B91D-4D5E-8188-3DA98D87838DQ40640416-341E9E20-CA44-4F14-A1A0-74F08CFAFA5CQ43949268-AD98730D-47C7-4A73-9412-CBC004F44AB0Q44041402-499A89FB-B221-47B9-A707-29A570706717Q44060393-49CE79DE-5BA2-4407-8226-7C448B8D8FD2Q45282194-05C20260-7806-4E0A-A86B-DC1E1AB20EEDQ46932542-4FB48E22-EFDD-429F-882B-13BA2BB4FDF7Q48004175-B187C85D-4466-4044-957A-48333FB8CF4BQ54397909-A09423E8-57C6-4791-B51D-0212765EDC0CQ54573052-D479A569-FE93-44E6-AC36-0D74265C41A4
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Immunobiology of vasoactive intestinal peptide (VIP)
@ast
Immunobiology of vasoactive intestinal peptide (VIP)
@en
type
label
Immunobiology of vasoactive intestinal peptide (VIP)
@ast
Immunobiology of vasoactive intestinal peptide (VIP)
@en
prefLabel
Immunobiology of vasoactive intestinal peptide (VIP)
@ast
Immunobiology of vasoactive intestinal peptide (VIP)
@en
P2093
P1433
P1476
Immunobiology of vasoactive intestinal peptide (VIP)
@en
P2093
Gomariz RP
Guerrero JM
Martínez M
P356
10.1016/S0167-5699(99)01525-X
P577
2000-01-01T00:00:00Z